The dopamine hypothesis of schizophrenia: a review - PubMed (original) (raw)

Review

The dopamine hypothesis of schizophrenia: a review

H Y Meltzer et al. Schizophr Bull. 1976.

No abstract available

PubMed Disclaimer

Similar articles

• Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
  Glowinski J. Glowinski J. Res Publ Assoc Res Nerv Ment Dis. 1975;54:233-46. Res Publ Assoc Res Nerv Ment Dis. 1975. PMID: 769114 Review. No abstract available.
• Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
  Fuxe K, Nyström M, Tovi M, Smith R, Ogren SO. Fuxe K, et al. J Psychiatr Res. 1974;11:151-61. doi: 10.1016/0022-3956(74)90087-9. J Psychiatr Res. 1974. PMID: 4156786 No abstract available.
• Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis.
  Fuxe K, Goldstein M, Hökfelt T, Jonsson G, Lidbrink P. Fuxe K, et al. Adv Neurol. 1974;5:405-19. Adv Neurol. 1974. PMID: 4374065 Review. No abstract available.
• Interaction between cholinergic and catecholaminergic neurones in rat brain.
  Corrodi H, Fuxe K, Lidbrink P. Corrodi H, et al. Brain Res. 1972 Aug 25;43(2):397-416. doi: 10.1016/0006-8993(72)90396-4. Brain Res. 1972. PMID: 4403347 No abstract available.
• Chemical specificity of dopamine transport in the nigro--neostriatal projection.
  McGeer EG, Searl K, Fibiger HC. McGeer EG, et al. J Neurochem. 1975 Feb;24(2):283-8. doi: 10.1111/j.1471-4159.1975.tb11877.x. J Neurochem. 1975. PMID: 234513 No abstract available.

Cited by

• Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort.
  Malén T, Santavirta S, De Maeyer S, Tuisku J, Kaasinen V, Kankare T, Isojärvi J, Rinne J, Hietala J, Nuutila P, Nummenmaa L. Malén T, et al. Neuroimage Clin. 2024;41:103578. doi: 10.1016/j.nicl.2024.103578. Epub 2024 Feb 13. Neuroimage Clin. 2024. PMID: 38395027 Free PMC article.
• Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.
  Baker GB, Greenshaw AJ. Baker GB, et al. Cell Mol Neurobiol. 1989 Mar;9(1):1-44. doi: 10.1007/BF00711441. Cell Mol Neurobiol. 1989. PMID: 2565769 Review.
• Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.
  Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA. Gray NS, et al. Psychopharmacology (Berl). 1992;107(2-3):425-30. doi: 10.1007/BF02245170. Psychopharmacology (Berl). 1992. PMID: 1615140 Clinical Trial.
• The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
  Howes OD, McCutcheon R, Owen MJ, Murray RM. Howes OD, et al. Biol Psychiatry. 2017 Jan 1;81(1):9-20. doi: 10.1016/j.biopsych.2016.07.014. Epub 2016 Aug 6. Biol Psychiatry. 2017. PMID: 27720198 Free PMC article. Review.
• Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat.
  Oakley NR, Hayes AG, Sheehan MJ. Oakley NR, et al. Psychopharmacology (Berl). 1991;105(2):204-8. doi: 10.1007/BF02244310. Psychopharmacology (Berl). 1991. PMID: 1686655

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database